Last updated: June 23, 2023
Sponsor: RWTH Aachen University
Overall Status: Completed
Phase
N/A
Condition
Fast Heart Rate (Tachycardia)
Memory Problems
Heart Disease
Treatment
leg crossing
Clinical Study ID
NCT03681080
17-006
Ages 18-60 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- AAN, SFN, hEDS, POTS or healthy control
- diagnosis in our clinic on the basis of anamnesis, clinical data as neurologicalexamination, tilt table, QST, skin biopsy, norepinephrine values, vitamine B12,antibodies
Exclusion
Exclusion Criteria: for all participants
- pregnancy, nonage,severe heart insufficiency, deep brain Stimulation, pace maker, drugconsumption, large fibre polyneuropathy for controls
- medication influencing blood pressure, psychiatric disease, synkopes or dizziness,neurological disorders esp. polyneuropathy, dementia, vitamine or iron deficiency
Study Design
Total Participants: 110
Treatment Group(s): 1
Primary Treatment: leg crossing
Phase:
Study Start date:
April 01, 2017
Estimated Completion Date:
May 30, 2023
Study Description
Connect with a study center
University Hospital, RWTH Aachen
Aachen, Nordrhein Westfalen 52074
GermanySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.